Healthcare Finance News October 31, 2023
Final rule increases payment for certain new renal dialysis drugs and biological products.
In a final rule, the Centers for Medicare and Medicaid Services is increasing the end-stage renal disease (ESRD) prospective payment system (PPS) base rate to $271.02, increasing total payments to ESRD facilities by about 2.1% in an update to payment rates and policies regarding renal dialysis services furnished to Medicare beneficiaries on or after January 1.
The rule also updates the acute kidney injury (AKI) dialysis payment rate for renal dialysis services furnished by ESRD facilities for 2024, and updates requirements for the ESRD Quality Incentive Program (QIP).
The CY 2024 ESRD PPS final rule also includes several changes related to ESRD PPS payment policies. First, this...